Nuance Investments LLC Decreases Stake in Agilent Technologies, Inc. $A

Nuance Investments LLC lowered its position in shares of Agilent Technologies, Inc. (NYSE:A) by 59.8% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 13,235 shares of the medical research company’s stock after selling 19,686 shares during the quarter. Nuance Investments LLC’s holdings in Agilent Technologies were worth $1,758,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of A. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after acquiring an additional 24,687 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Agilent Technologies by 20.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock worth $7,269,000 after purchasing an additional 9,236 shares during the last quarter. Dudley & Shanley Inc. raised its holdings in shares of Agilent Technologies by 25.9% during the second quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after acquiring an additional 14,300 shares during the last quarter. Crossmark Global Holdings Inc. raised its stake in Agilent Technologies by 39.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock valued at $4,615,000 after purchasing an additional 9,615 shares during the last quarter. Finally, Capricorn Fund Managers Ltd purchased a new position in shares of Agilent Technologies in the first quarter worth about $8,161,000.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. TD Cowen lifted their price objective on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Morgan Stanley upped their price objective on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Piper Sandler assumed coverage on Agilent Technologies in a report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price for the company. Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Finally, Wells Fargo & Company lowered their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies Stock Performance

Shares of A stock opened at $148.65 on Tuesday. The firm has a market cap of $41.98 billion, a price-to-earnings ratio of 29.85, a PEG ratio of 2.63 and a beta of 1.25. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The stock’s 50-day moving average is $135.70 and its two-hundred day moving average is $125.58. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts predict that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.